Veracity Capital’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-9,891
Closed -$233K – 223
2020
Q3
$233K Buy
9,891
+328
+3% +$7.71K 0.13% 163
2020
Q2
$212K Sell
9,563
-11,195
-54% -$232K 0.12% 167
2020
Q1
$381K Buy
20,758
+330
+2% +$6.65K 0.11% 132
2019
Q4
$428K Buy
+20,428
New +$405K 0.11% 140

Other funds holding BOUT

Veracity Capital's BOUT Position: Q4 2020 in Review

Veracity Capital sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q4 2020, closing a stake of 9,891 shares — an estimated $233K sold.

Veracity Capital first reported a position in BOUT in Q4 2019 and held it in 4 quarters. The position peaked at $428K in Q4 2019. 10 funds tracked by Wall St. Rank hold BOUT as of Q4 2020.

  • Veracity Capital reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q4 2020 after selling out during the quarter.
  • Veracity Capital sold 9,891 CapForce IBD Breakout Opportunities ETF shares in Q4 2020, an estimated $233K.
  • Veracity Capital first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2019 and held it in 4 quarters.
  • Veracity Capital's CapForce IBD Breakout Opportunities ETF position peaked at $428K in Q4 2019.
  • 10 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q4 2020.

Based on Veracity Capital's 13F filing for Q4 2020, filed 25 Jan 2021.